Peijia Medical Ltd. Announces Successful First Implantation in Clinical Trial of Sutra Hemi-valve Transcatheter Mitral Valve Repair System

Peijia Medical Limited has announced the successful completion of the first implantation in the first-in-man clinical trial of its Sutra Hemi-valve Transcatheter Mitral Valve Repair System. The procedure was conducted at Waikato Hospital in New Zealand on an 83-year-old high-risk patient with severe functional mitral regurgitation, a condition for which conventional treatment options were unsuitable. The patient recovered well and was discharged from the hospital on the third day. The company, which holds a strategic investment in Sutra Medical, Inc., a U.S.-based medical device company, emphasizes that while this development marks significant progress, the successful development or marketing of the Sutra Hemi-valve cannot be guaranteed. Results of this clinical trial have been presented following the procedure. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Peijia Medical Ltd. published the original content used to generate this news brief on September 11, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here